CRW vs. ONT, UPR, PRTC, SPI, AMS, GNS, BMK, NIOX, MXCT, and OXB
Should you be buying Craneware stock or one of its competitors? The main competitors of Craneware include Oxford Nanopore Technologies (ONT), Uniphar (UPR), PureTech Health (PRTC), Spire Healthcare Group (SPI), Advanced Medical Solutions Group (AMS), Genus (GNS), Benchmark (BMK), NIOX Group (NIOX), MaxCyte (MXCT), and Oxford Biomedica (OXB). These companies are all part of the "medical" sector.
Craneware (LON:CRW) and Oxford Nanopore Technologies (LON:ONT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations.
In the previous week, Craneware and Craneware both had 4 articles in the media. Oxford Nanopore Technologies' average media sentiment score of 1.27 beat Craneware's score of 0.30 indicating that Oxford Nanopore Technologies is being referred to more favorably in the news media.
Craneware has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.
Craneware has a net margin of 5.19% compared to Oxford Nanopore Technologies' net margin of -91.06%. Craneware's return on equity of 2.86% beat Oxford Nanopore Technologies' return on equity.
58.1% of Craneware shares are owned by institutional investors. Comparatively, 38.5% of Oxford Nanopore Technologies shares are owned by institutional investors. 20.8% of Craneware shares are owned by insiders. Comparatively, 30.0% of Oxford Nanopore Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Craneware has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500. Comparatively, Oxford Nanopore Technologies has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500.
Craneware received 208 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 71.43% of users gave Craneware an outperform vote.
Craneware presently has a consensus price target of GBX 2,600, suggesting a potential upside of 9.24%. Oxford Nanopore Technologies has a consensus price target of GBX 303.75, suggesting a potential upside of 173.40%. Given Oxford Nanopore Technologies' higher possible upside, analysts plainly believe Oxford Nanopore Technologies is more favorable than Craneware.
Summary
Craneware beats Oxford Nanopore Technologies on 9 of the 16 factors compared between the two stocks.
Get Craneware News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Craneware Competitors List
Related Companies and Tools
